- Alembic Pharmaceuticals has received a tentative nod for the US drug regulator for empagliflozin and linagliptin tablets.
- The company has received US Food & Drug Administration (USFDA) tentative approval for empagliflozin and linagliptin Tablets, 10 mg/5 mg and 25 mg/5 mg. Alembic now has a total of 130 ANDA approvals (113 final approvals and 17 tentative approvals) from the FDA.
No comments:
Post a Comment